Interaction between non-coding RNAs and JNK in human disorders

Soudeh Ghafouri-Fard1, Atefe Abak2, Mahdi Mohaqiq3

  • 1Department of Medical Genetics, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Insights

The Jun N-terminal Kinase (JNK) pathway, involving microRNAs (miRNAs) and long non-coding RNAs (lncRNAs), plays a critical role in human diseases. Understanding this JNK-miRNA/lncRNA interaction is key to developing new therapeutic strategies.

Area of Science:

  • Molecular Biology
  • Cell Signaling
  • Genetics

Background:

  • The Jun N-terminal Kinase (JNK) signaling pathway is crucial for cellular processes like gene expression, cytoskeletal organization, and apoptosis.
  • JNK signaling is implicated in both normal development and disease, including cancer and inflammatory disorders.
  • MicroRNAs (miRNAs) and long non-coding RNAs (lncRNAs) are known regulators of gene expression and have functional links to JNK pathways.

Purpose of the Study:

  • To review the functional interactions between JNK signaling pathways and regulatory RNAs (miRNAs and lncRNAs).
  • To elucidate the role of these JNK-miRNA/lncRNA interactions in the pathobiology of various human disorders.
  • To highlight the contribution of these interactions to both non-malignant and malignant conditions.

Main Methods:

  • Literature review of studies investigating JNK signaling, miRNAs, and lncRNAs.
  • Analysis of research on the involvement of JNK-related regulatory RNAs in disease pathogenesis.
  • Synthesis of findings on the role of these interactions in human disorders.

Main Results:

  • JNK signaling pathways are intricately connected with specific miRNAs and lncRNAs.
  • These interactions are implicated in the pathogenesis of diverse conditions, including traumatic brain injury, inflammatory diseases, and cardiovascular events.
  • JNK-associated miRNAs and lncRNAs are significantly involved in the development and progression of various cancers, such as lung, liver, and colon cancer.

Conclusions:

  • The interplay between JNK signaling and regulatory RNAs (miRNAs/lncRNAs) is a significant factor in human disease.
  • Targeting these interactions presents a potential therapeutic avenue for managing a range of disorders, including cancers.
  • Further research into JNK-miRNA/lncRNA mechanisms can lead to novel diagnostic and therapeutic strategies.

Related Concept Videos

lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.3K
Types of RNA01:20

Types of RNA

Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in regulating gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA Performs Diverse...
8.1K
Types of RNA01:23

Types of RNA

Overview
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
70.4K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
10.1K
Alternative RNA Splicing02:18

Alternative RNA Splicing

Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
23.6K
Chromatin Structure Regulates pre-mRNA Processing02:41

Chromatin Structure Regulates pre-mRNA Processing

In eukaryotic cells, nascent mRNA transcripts need to undergo many post-transcriptional modifications to reach the cell cytoplasm and translate into functional proteins. For a long time, transcription and pre-mRNA processing were considered two independent events that occur sequentially in the cell. However, it has now been well established that transcription and pre-mRNA processing are two simultaneous processes that are precisely regulated inside the cell.
The chromatin structure, especially...
7.6K